- Speak with us
Next Generation Dx Summit
Takara Bio joined diagnostics professionals to discuss a range of topics including point-of-care diagnostics, liquid biopsies, immuno-oncology, and companion diagnostics at the Next Generation Dx Summit 2019 in Washington, DC.
To learn about our support for clinical research, we invite you to explore our learning resources. Please reach out to us with any questions or requests via the "speak with us" link below.
Support for clinical research
Cancer immunotherapy is a promising approach for cancer treatment and holds several key advantages over traditional therapies, including high specificity, little or no side effects, and a good safety profile.
Learn how CAR T-cell therapies are making cancer treatment targeted, safer, and better.
A novel protocol that enables the detection of both SNVs and CNVs from 1-5 cells in a single, low-pass sequencing run that saves time and money.
Learn more about how our Titanium Taq provided robust and sensitive amplification in breast cancer research.
Getting ready to sequence T-cell and B-cell receptors? Check out these tips to help you make key decisions before you start.
Summary of two recent papers describing the use of plasma-seq technology for cancer research.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2019 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.